Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment

G Gezgin; M Dogrusoz; TH van Essen; WGM Kroes; GPM Luyten; PA Van der Velden; V Walter; Rob Verdijk; T van Hall; SH van der Burg; MJ Jager

doi:10.1007/s00262-017-1991-1

Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment

G Gezgin, M Dogrusoz, TH van Essen, WGM Kroes, GPM Luyten, PA Van der Velden, V Walter, Rob Verdijk, T van Hall, SH van der Burg, MJ Jager

Pathology

Research output: Contribution to journal › Article › Academic › peer-review

95 Citations (Scopus)

20 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	903-912
Number of pages	10
Journal	Cancer Immunology Immunotherapy
Volume	66
Issue number	7
DOIs	https://doi.org/10.1007/s00262-017-1991-1
Publication status	Published - 2017

Research programs

EMC OR-01

Access to Document

10.1007/s00262-017-1991-1

art-3A10.1007-2Fs00262-017-1991-1.pdfFinal published version, 864 KB

http://hdl.handle.net/1765/99134

Cite this

@article{ed3a42a3507944d897b73c76394d1a93,

title = "Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment",

author = "G Gezgin and M Dogrusoz and {van Essen}, TH and WGM Kroes and GPM Luyten and {Van der Velden}, PA and V Walter and Rob Verdijk and {van Hall}, T and {van der Burg}, SH and MJ Jager",

year = "2017",

doi = "10.1007/s00262-017-1991-1",

language = "Undefined/Unknown",

volume = "66",

pages = "903--912",

journal = "Cancer Immunology Immunotherapy",

issn = "0340-7004",

publisher = "Springer Science+Business Media",

number = "7",

}

TY - JOUR

T1 - Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment

AU - Gezgin, G

AU - Dogrusoz, M

AU - van Essen, TH

AU - Kroes, WGM

AU - Luyten, GPM

AU - Van der Velden, PA

AU - Walter, V

AU - Verdijk, Rob

AU - van Hall, T

AU - van der Burg, SH

AU - Jager, MJ

PY - 2017

Y1 - 2017

U2 - 10.1007/s00262-017-1991-1

DO - 10.1007/s00262-017-1991-1

M3 - Article

C2 - 28391358

SN - 0340-7004

VL - 66

SP - 903

EP - 912

JO - Cancer Immunology Immunotherapy

JF - Cancer Immunology Immunotherapy

IS - 7

ER -